Apligraf - an FDA-approved, bioengineered living-cell therapy from Organogenesis Inc. - has become the first wound-healing therapy to demonstrate a significant change in the genomic profile of a treated non-healing wound, according to new research published in the peer-reviewed journal Science Translational Medicine.
Scars are often the unwanted and permanent result of wound healing, but University of California, Irvine and University of Pennsylvania researchers have discovered a natural regeneration process that stimulates scar-free skin repair.
A protein thought to fuel pancreatic cancer development plays a much more complicated role, a new study finds.
Malignant melanoma is the fastest-growing type of cancer and the most fatal skin disease.
Pág. 12 de 12